Suppr超能文献

获取乳腺癌患者骨活检标本的策略——既往经验与未来方向。

Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions.

作者信息

Ibrahim Mohammed F K, Hilton John, Addison Christina, Robertson Susan, Werier Joel, Mazzarello Sasha, Vandermeer Lisa, Jacobs Carmel, Clemons Mark

机构信息

Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Ontario, Canada.

Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada.

出版信息

J Bone Oncol. 2016 Jul 7;5(4):180-184. doi: 10.1016/j.jbo.2016.07.001. eCollection 2016 Nov.

Abstract

BACKGROUND

Cancer and its treatment can have multiple effects on the bone. Despite the widespread use of in vivo and in vitro models, it is still necessary to understand these effects in humans. Obtaining human bone biopsies is technically challenging and in this article we review the experiences from the Ottawa Bone Oncology Program.

METHODS

A series of bone biopsy studies in breast cancer patients with and without bone metastasis have been performed. We reviewed the results of these studies and present them in a descriptive manner. We discuss lessons learned from each project and how they have affected future directions for research.

RESULTS

Since 2009, 5 studies have been performed accruing 97 breast cancer patients. Study endpoints have ranged from comparing the yield of malignant cells from CT-guided versus standard iliac crest biopsies, to studies assessing the feasibility of micro-CT analysis on Jedhadi trephines to evaluate bisphosphonate effects on bone micro-architecture. More recently, we have assessed the feasibility of performing repeat bone biopsies in the same patient as well as evaluating the practicality of obtaining bone tissue at the time of orthopaedic surgery.

CONCLUSION

Human bone tissue is an important biological resource. Our experience suggests that obtaining bone biopsies is feasible and can yield adequate amount of tumour cells for many studies. However, these remain technically challenging specimens to obtain and given the rapid advances in cancer therapeutics and the use of potent adjuvant bone-targeted agents, more centres need to be involved in these types of studies.

摘要

背景

癌症及其治疗会对骨骼产生多种影响。尽管体内和体外模型被广泛应用,但仍有必要了解这些影响在人类身上的情况。获取人类骨活检在技术上具有挑战性,在本文中我们回顾了渥太华骨肿瘤项目的经验。

方法

对一系列有或无骨转移的乳腺癌患者进行了骨活检研究。我们回顾了这些研究的结果并以描述性方式呈现。我们讨论了从每个项目中学到的经验教训以及它们如何影响未来的研究方向。

结果

自2009年以来,已开展了5项研究,纳入了97例乳腺癌患者。研究终点范围从比较CT引导下与标准髂嵴活检获取恶性细胞的成功率,到评估对杰哈迪环钻进行显微CT分析以评估双膦酸盐对骨微结构影响的可行性。最近,我们评估了在同一患者中进行重复骨活检的可行性以及在骨科手术时获取骨组织的实用性。

结论

人类骨组织是一种重要的生物资源。我们的经验表明,获取骨活检是可行的,并且可为许多研究提供足够数量的肿瘤细胞。然而,获取这些标本在技术上仍然具有挑战性,鉴于癌症治疗方法的快速发展以及强效辅助性骨靶向药物的使用,需要更多中心参与这类研究。

相似文献

1
Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions.
J Bone Oncol. 2016 Jul 7;5(4):180-184. doi: 10.1016/j.jbo.2016.07.001. eCollection 2016 Nov.
2
Acquisition of metastatic tissue from patients with bone metastases from breast cancer.
Breast Cancer Res Treat. 2011 Oct;129(3):761-5. doi: 10.1007/s10549-010-1264-6. Epub 2010 Nov 27.
3
Results of iliac crest biopsies taken from 1465 patients with primary breast cancer.
J Cancer Res Clin Oncol. 1998 Jan;124(1):44-8. doi: 10.1007/s004320050132.
5
Bisphosphonates for breast cancer.
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003474. doi: 10.1002/14651858.CD003474.pub2.
6
Overview of resistance to systemic therapy in patients with breast cancer.
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
8
Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
BJU Int. 2012 Dec;110(11):1742-6. doi: 10.1111/j.1464-410X.2012.11124.x. Epub 2012 Apr 13.
9
Bisphosphonates for breast cancer.
Cochrane Database Syst Rev. 2002(1):CD003474. doi: 10.1002/14651858.CD003474.

引用本文的文献

1
Unlocking bone for proteomic analysis and FISH.
Lab Invest. 2019 May;99(5):708-721. doi: 10.1038/s41374-018-0168-7. Epub 2019 Jan 18.

本文引用的文献

2
Bone-targeted therapy for metastatic breast cancer-Where do we go from here? A commentary from the BONUS 8 meeting.
J Bone Oncol. 2014 Feb 4;3(1):1-4. doi: 10.1016/j.jbo.2014.01.001. eCollection 2014 Mar.
3
A national portfolio of bone oncology trials-The Canadian experience in 2012.
J Bone Oncol. 2012 Oct 17;1(3):95-100. doi: 10.1016/j.jbo.2012.09.001. eCollection 2012 Dec.
5
Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?
J Bone Oncol. 2012 May 24;1(1):12-7. doi: 10.1016/j.jbo.2012.04.003. eCollection 2012 Jun.
8
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
Lancet. 2015 Oct 3;386(10001):1353-1361. doi: 10.1016/S0140-6736(15)60908-4. Epub 2015 Jul 23.
9
Invasive Pleomorphic Lobular Carcinoma of the Breast: Pathologic, Clinical, and Therapeutic Considerations.
Clin Breast Cancer. 2015 Dec;15(6):421-5. doi: 10.1016/j.clbc.2015.06.010. Epub 2015 Jun 22.
10
Treatment choices for patients with invasive lobular breast cancer: a doctor survey.
J Eval Clin Pract. 2015 Aug;21(4):740-8. doi: 10.1111/jep.12379. Epub 2015 Jun 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验